sur Marinomed Biotech AG
Marinomed Biotech AG Announces Closure Following Insolvency
On September 24, 2026, Marinomed Biotech AG, based in Korneuburg, Austria, disclosed the cessation of its operations due to insolvency. The company's administrator, Dr. Ulla Reisch, initiated the closure process during a court hearing.
The decision follows unsuccessful attempts to maintain operations. Plans for a licensing rights sale failed to materialize in time, and negotiations with prospective investors did not yield positive outcomes. As a result, the insolvency court ordered the business to close.
The insolvency administrator will proceed with selling the company's assets. Marinomed Biotech AG has committed to providing updates on subsequent legal and operational initiatives as new information becomes available.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Marinomed Biotech AG